genOway S.A.

Paris Stock Exchange:ALGEN.PA

Sector

🏥 Health Care

Industries

🧬 Biotechnology

💊 Pharmaceuticals

🔍 Research & Consulting

Location

France

Market Cap

USD 32.97 M

Share Price

USD 3.61

Avg Daily Volume

3,147

Change (1 day)

0.40%

Change (1 year)

-17.33%

Change (YTD)

-6.92%

genOway S.A. Operating Cash Flow for the year ending December 31, 2021: USD -639.01 K

genOway S.A. Operating Cash Flow is USD -639.01 K for the year ending December 31, 2021, a 218.33% change year over year. Operating cash flow is cash generated from the company’s regular business operations.

genOway S.A. Operating Cash Flow for the year ending December 31, 2020 was USD -200.74 K.

Competitors

Eli Lilly and Company

USD 746.37

LLY

-19.58 -2.56%

AbbVie Inc.

USD 196.30

ABBV

-2.25 -1.13%

Roche Holding AG

USD 322.52

RO.SW

-10.06 -3.03%

AstraZeneca PLC

USD 150.15

AZN.L

-2.01 -1.32%

Merck & Co., Inc.

USD 79.44

MRK

-1.35 -1.67%

Thermo Fisher Scientific Inc.

USD 448.94

TMO

-17.48 -3.75%

Amgen Inc.

USD 284.67

AMGN

-15.41 -5.13%

Sanofi

USD 92.89

SAN.PA

-2.06 -2.17%

Vertex Pharmaceuticals Incorporated

USD 385.65

VRTX

+10.67 2.84%

Chugai Pharmaceutical Co., Ltd.

USD 49.92

4519.T

-0.37 -0.73%

Regeneron Pharmaceuticals, Inc.

USD 555.13

REGN

-14.77 -2.59%

MERCK Kommanditgesellschaft auf Aktien

USD 123.06

MRK.DE

-1.83 -1.47%

Samsung Biologics Co.,Ltd.

USD 742.81

207940.KS

+2.56 0.34%

Daiichi Sankyo Company, Limited

USD 24.51

4568.T

-0.31 -1.23%

Ucb S.A.

USD 213.13

UCB.BR

-3.15 -1.46%

View all

Key Data

Date	Operating Cash Flow	Capital Expenditure	Net Cash Used For Investing Activities	Net Cash Used Provided By Financing Activities